Pre- and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir

New strategies to prevent and treat influenza virus infections are urgently needed. A recently discovered class of monoclonal antibodies (mAbs) neutralizing an unprecedented spectrum of influenza virus subtypes may have the potential for future use in humans. Here, we assess the efficacies of CR6261...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Koudstaal, Wouter, Koldijk, Martin H., Brakenhoff, Just P. J., Cornelissen, Lisette A. H. M., Weverling, Gerrit Jan, Friesen, Robert H. E., Goudsmit, Jaap
Format: Artigo
Idioma:Inglês
Publicat: The University of Chicago Press 2009
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7110231/
https://ncbi.nlm.nih.gov/pubmed/19911992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/648378
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars